Los anticuerpos monoclonales (mAbs) se han utilizado para tratar muchas enfermedades, incluida la COVID-19 y virus respiratorio sincitial (VRS).
Esta hoja informativa del NFID en español proporciona información sobre los anticuerpos monoclonales (mAbs) y las diferencias entre las vacunas y los mAbs.
View in English
Related Resources
2024 National Survey: Attitudes and Behaviors about Influenza, COVID-19, Respiratory Syncytial Virus, and Pneumococcal Disease
2024 national survey on flu, RSV, COVID-19, and pneumococcal disease
Contagious Chronicles: Updated Recommendations for Respiratory Season
In this episode, NFID experts discuss updated recommendations to help protect against COVID-19, influenza (flu), respiratory syncytial virus (RSV), and pneumococcal disease …
Sonya’s Story (COVID-19)
A daughter prays that her mother’s death helps others understand the dangers of COVID-19